BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anastos K, Lu D, Shi Q, Tien PC, Kaplan RC, Hessol NA, Cole S, Vigen C, Cohen M, Young M. Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr. 2007;45:34-42. [PMID: 17460470 DOI: 10.1097/qai.0b013e318042d5fe] [Cited by in Crossref: 80] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS. Monocytes as regulators of inflammation and HIV-related comorbidities during cART. J Immunol Res 2014;2014:569819. [PMID: 25025081 DOI: 10.1155/2014/569819] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
2 Marín-Palma D, Castro GA, Cardona-Arias JA, Urcuqui-Inchima S, Hernandez JC. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection Are Associated With Increased Inflammatory Markers and Disease Progression. Front Immunol 2018;9:1350. [PMID: 29963050 DOI: 10.3389/fimmu.2018.01350] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 So-Armah KA, Chang J, Alcorn C, Lo Re V, Baker JV, Tracy R, Butt AA, Agan BK, Rimland D, Gibert CL, Goetz MB, Oursler KK, Rodriguez-Barradas MC, Kuller LH, Brown ST, Stein JH, Skanderson M, Justice AC, Freiberg MS. HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function. Curr HIV Res 2014;12:50-9. [PMID: 25034208 DOI: 10.2174/1570162x1201140716101512] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
4 Obirikorang C, Acheampong E, Quaye L, Yorke J, Amos-Abanyie EK, Akyaw PA, Anto EO, Bani SB, Asamoah EA, Batu EN. Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study. PLoS One 2020;15:e0227779. [PMID: 31929604 DOI: 10.1371/journal.pone.0227779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Mocumbi AO, Dobe I, Cândido S, Kim N. Cardiovascular risk and D-dimer levels in HIV-infected ART-naïve Africans. Cardiovasc Diagn Ther 2020;10:526-33. [PMID: 32695632 DOI: 10.21037/cdt.2019.12.02] [Reference Citation Analysis]
6 Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011;8:405-415. [PMID: 21629239 DOI: 10.1038/nrgastro.2011.91] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
7 Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S, Tien PC; Fat Redistribution and Metabolic Changes in HIV Infection Study Investigators. Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr 2008;48:35-43. [PMID: 18197118 DOI: 10.1097/QAI.0b013e318164227f] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
8 Vasunilashorn S, Crimmins EM, Kim JK, Winking J, Gurven M, Kaplan H, Finch CE. Blood lipids, infection, and inflammatory markers in the Tsimane of Bolivia. Am J Hum Biol 2010;22:731-40. [PMID: 20721985 DOI: 10.1002/ajhb.21074] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 6.2] [Reference Citation Analysis]
9 Pond RA, Collins LF, Lahiri CD. Sex Differences in Non-AIDS Comorbidities Among People With Human Immunodeficiency Virus. Open Forum Infect Dis 2021;8:ofab558. [PMID: 34888399 DOI: 10.1093/ofid/ofab558] [Reference Citation Analysis]
10 Anastos K, Ndamage F, Lu D, Cohen MH, Shi Q, Lazar J, Bigirimana V, Mutimura E. Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women. AIDS Res Ther 2010;7:34. [PMID: 20796311 DOI: 10.1186/1742-6405-7-34] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kinoo SM, Chuturgoon AA, Singh B, Nagiah S. Hepatic expression of cholesterol regulating genes favour increased circulating low-density lipoprotein in HIV infected patients with gallstone disease: a preliminary study. BMC Infect Dis 2021;21:294. [PMID: 33757439 DOI: 10.1186/s12879-021-05977-0] [Reference Citation Analysis]
12 Tsai FJ, Ho MW, Lai CH, Chou CH, Li JP, Cheng CF, Wu YC, Liu X, Tsang H, Lin TH, Liao CC, Huang SM, Lin JC, Lin CC, Hsieh CL, Liang WM, Lin YJ. Evaluation of Oral Antiretroviral Drugs in Mice With Metabolic and Neurologic Complications. Front Pharmacol 2018;9:1004. [PMID: 30233379 DOI: 10.3389/fphar.2018.01004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
13 Barillari G. The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process. Int J Mol Sci 2020;21:E4526. [PMID: 32630531 DOI: 10.3390/ijms21124526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
14 Sinxadi PZ, McIlleron HM, Dave JA, Smith PJ, Levitt NS, Maartens G. Association of lopinavir concentrations with plasma lipid or glucose concentrations in HIV-infected South Africans: a cross sectional study. AIDS Res Ther 2012;9:32. [PMID: 23098156 DOI: 10.1186/1742-6405-9-32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Osegbe I, Ugonabo M, Chukwuka C, Meka I, Nwosu N. Comparison of calculated versus directly-measured low-density lipoprotein-cholesterol: An evaluation of ten formulas for an HIV-positive population in Sub-Saharan Africa. J Lab Physicians 2017;9:111-5. [PMID: 28367026 DOI: 10.4103/0974-2727.199632] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Nglazi MD, West SJ, Dave JA, Levitt NS, Lambert EV. Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa. BMC Public Health 2014;14:676. [PMID: 24990360 DOI: 10.1186/1471-2458-14-676] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
17 Oni T, Unwin N. Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition. Int Health 2015;7:390-9. [PMID: 26103981 DOI: 10.1093/inthealth/ihv040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
18 Ekun OA, Fasela EO, Oladele DA, Liboro GO, Raheem TY. Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria. Pan Afr Med J 2021;38:206. [PMID: 33995812 DOI: 10.11604/pamj.2021.38.206.26791] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Santiprabhob J, Tanchaweng S, Maturapat S, Maleesatharn A, Lermankul W, Sricharoenchai S, Wittawatmongkol O, Lapphra K, Phongsamart W, Chokephaibulkit K. Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors. Biomed Res Int 2017;2017:7481597. [PMID: 28293638 DOI: 10.1155/2017/7481597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
20 Amado Costa L, Almeida AG. Cardiovascular disease associated with human immunodeficiency virus: A review. Revista Portuguesa de Cardiologia (English Edition) 2015;34:479-91. [DOI: 10.1016/j.repce.2015.06.008] [Reference Citation Analysis]
21 Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther 2012;9:31. [PMID: 23095661 DOI: 10.1186/1742-6405-9-31] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
22 Tsai FJ, Cheng CF, Lai CH, Wu YC, Ho MW, Wang JH, Tien N, Liu X, Tsang H, Lin TH, Liao CC, Huang SM, Li JP, Lin JC, Lin CC, Chen JH, Liang WM, Lin YJ. Effect of antiretroviral therapy use and adherence on the risk of hyperlipidemia among HIV-infected patients, in the highly active antiretroviral therapy era. Oncotarget 2017;8:106369-81. [PMID: 29290955 DOI: 10.18632/oncotarget.22465] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
23 Kuniholm MH, Liang H, Anastos K, Gustafson D, Kassaye S, Nowicki M, Sha BE, Pawlowski EJ, Gange SJ, Aouizerat BE, Pushkarsky T, Bukrinsky MI, Prasad VR. Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women. AIDS 2017;31:2483-92. [PMID: 29120899 DOI: 10.1097/QAD.0000000000001648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hamooya BM, Musonda P, Mutale W, Masenga SK, Halwiindi H, Mutengo KH, Chiyeñu KOR, Chongwe G, Koethe JR, Lipworth L, Heimburger DC. Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings. PLoS One 2021;16:e0247004. [PMID: 33592027 DOI: 10.1371/journal.pone.0247004] [Reference Citation Analysis]
25 Pirrone V, Libon DJ, Sell C, Lerner CA, Nonnemacher MR, Wigdahl B. Impact of age on markers of HIV-1 disease. Future Virol 2013;8:81-101. [PMID: 23596462 DOI: 10.2217/fvl.12.127] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
26 Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN, Levitt NS, Crowther NJ, Nyirenda M, Njelekela M. Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis. Int J Epidemiol. 2013;42:1754-1771. [PMID: 24415610 DOI: 10.1093/ije/dyt198] [Cited by in Crossref: 109] [Cited by in F6Publishing: 114] [Article Influence: 13.6] [Reference Citation Analysis]
27 Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, Hatano H, Xie Y, Martin JN, Ganz P, Deeks SG. Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS 2009;23:2021-7. [PMID: 19542863 DOI: 10.1097/QAD.0b013e32832e7140] [Cited by in Crossref: 117] [Cited by in F6Publishing: 53] [Article Influence: 9.0] [Reference Citation Analysis]
28 Bernal E, Masiá M, Padilla S, Gutiérrez F. High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition. AIDS Patient Care STDS 2008;22:569-75. [PMID: 18479224 DOI: 10.1089/apc.2007.0186] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
29 Barillari G. The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs. Front Oncol 2020;10:806. [PMID: 32528888 DOI: 10.3389/fonc.2020.00806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Osegbe ID, Soriyan OO, Ogbenna AA, Okpara HC, Azinge EC. Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a Nigerian tertiary hospital. Pan Afr Med J 2016;23:206. [PMID: 27347295 DOI: 10.11604/pamj.2016.23.206.7041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
31 Womack JA, Scherzer R, Cole SR, Fennie K, Williams AB, Grey M, Minkoff H, Anastos K, Cohen MH, Tien PC. Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection. J Acquir Immune Defic Syndr 2009;52:581-7. [PMID: 19950431 DOI: 10.1097/qai.0b013e3181b9e5ee] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
32 Ramos-Sanchez EM, Goto H, Rivero DH, Mauad T, de Souza FN, Monteiro AM, Gidlund M. In vivo assessment of antiretroviral therapy-associated side effects. Mem Inst Oswaldo Cruz 2014;109:484-7. [PMID: 25075786 DOI: 10.1590/0074-0276130559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Gebhardt A, Fichtenbaum CJ. Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection. Expert Opin Pharmacother 2019;20:1719-29. [PMID: 31232617 DOI: 10.1080/14656566.2019.1636033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Dave JA, Levitt NS, Ross IL, Lacerda M, Maartens G, Blom D. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients. PLoS One 2016;11:e0151911. [PMID: 26986065 DOI: 10.1371/journal.pone.0151911] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
35 Crane HM, Grunfeld C, Willig JH, Mugavero MJ, Van Rompaey S, Moore R, Rodriguez B, Feldman BJ, Lederman MM, Saag MS, Kitahata MM. Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care. AIDS 2011;25:185-95. [PMID: 21150555 DOI: 10.1097/QAD.0b013e328341f925] [Cited by in Crossref: 62] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
36 Patel P, Rose CE, Collins PY, Nuche-Berenguer B, Sahasrabuddhe VV, Peprah E, Vorkoper S, Pastakia SD, Rausch D, Levitt NS; NIH HIV/NCD Project Disease Condition Technical Operating Group. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis. AIDS 2018;32 Suppl 1:S5-S20. [PMID: 29952786 DOI: 10.1097/QAD.0000000000001888] [Cited by in Crossref: 101] [Cited by in F6Publishing: 74] [Article Influence: 25.3] [Reference Citation Analysis]
37 Sridevi K, Malathi S, Kv C, G CN, Gayathri M, Chand GE, Nayyar AS. CD4 Cell Counts, Lipid Profile, and Oral Manifestations in HIV-Infected and AIDS Patients. Front Dent 2019;16:436-49. [PMID: 33089245 DOI: 10.18502/fid.v16i6.3443] [Reference Citation Analysis]
38 Lazar J, Holman S, Minkoff HL, Dehovitz JA, Sharma A. Interarm blood pressure differences in the women's interagency HIV study. AIDS Res Hum Retroviruses 2008;24:695-700. [PMID: 18507529 DOI: 10.1089/aid.2007.0237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
39 Maskew M, Westreich D, Fox MP, Maotoe T, Sanne IM. Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa. J Int AIDS Soc 2012;15:13. [PMID: 22410312 DOI: 10.1186/1758-2652-15-13] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
40 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
41 Floris-Moore M, Fayad ZA, Berman JW, Mani V, Schoenbaum EE, Klein RS, Weinshelbaum KB, Fuster V, Howard AA, Lo Y, Schecter AD. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS 2009;23:941-9. [PMID: 19318907 DOI: 10.1097/QAD.0b013e328329c76b] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
42 Palacios R, Puerta S, Orihuela F, Olalla J, Roldán J, Grana M, Márquez M, Colmenero JD, Santos J; Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patients. AIDS Res Hum Retroviruses 2010;26:1167-70. [PMID: 20929391 DOI: 10.1089/aid.2009.0284] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
43 Leroyer S, Vatier C, Kadiri S, Quette J, Chapron C, Capeau J, Antoine B. Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue. J Lipid Res 2011;52:207-20. [PMID: 21068005 DOI: 10.1194/jlr.M000869] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
44 Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Guaraldi G, Guerra B, Meloni AM, Vimercati A, Molinari A, Pinnetti C, Dalzero S, Ravizza M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. Plasma lipid profile in pregnant women with HIV receiving nevirapine. AIDS Patient Care STDS 2009;23:147-52. [PMID: 19866532 DOI: 10.1089/apc.2008.0148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
45 Patel P, Sabin K, Godfrey-Faussett P. Approaches to Improve the Surveillance, Monitoring, and Management of Noncommunicable Diseases in HIV-Infected Persons: Viewpoint. JMIR Public Health Surveill 2018;4:e10989. [PMID: 30573446 DOI: 10.2196/10989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
46 Estrada V, Geijo P, Fuentes-Ferrer M, Alcalde ML, Rodrigo M, Galindo MJ, Muñoz A, Domingo P, Ribera E, Cosín J, Viciana P, Lozano F, Terrón A, Vergara A, Teira R, Muñoz-Sánchez J, Roca B, Sánchez T, López-Aldeguer J, Deig E, Vidal F, Pedrol E, Castaño-Carracedo M, Puig T, Garrido M, Suárez-Lozano I. Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort. BMC Womens Health 2011;11:36. [PMID: 21816091 DOI: 10.1186/1472-6874-11-36] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
47 Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D’Arminio Monforte A, Friis-Møller N. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration. Lancet. 2008;371:1417-1426. [PMID: 18387667 DOI: 10.1016/s0140-6736(08)60423-7] [Cited by in Crossref: 585] [Cited by in F6Publishing: 230] [Article Influence: 41.8] [Reference Citation Analysis]
48 Mujawar Z, Tamehiro N, Grant A, Sviridov D, Bukrinsky M, Fitzgerald ML. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry 2010;49:8338-49. [PMID: 20731376 DOI: 10.1021/bi100466q] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
49 Feeney ER, Mallon PW. HIV and HAART-Associated Dyslipidemia. Open Cardiovasc Med J 2011;5:49-63. [PMID: 21643501 DOI: 10.2174/1874192401105010049] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 7.6] [Reference Citation Analysis]
50 Padmapriyadarsini C, Ramesh Kumar S, Terrin N, Narendran G, Menon PA, Ramachandran G, Subramanyan S, Venkatesan P, Wanke C, Swaminathan S. Dyslipidemia among HIV-infected Patients with tuberculosis taking once-daily nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in India. Clin Infect Dis 2011;52:540-6. [PMID: 21252141 DOI: 10.1093/cid/ciq195] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
51 Parrinello CM, Landay AL, Hodis HN, Gange SJ, Norris PJ, Young M, Anastos K, Tien PC, Xue X, Lazar J, Benning L, Tracy RP, Kaplan RC. Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis 2012;225:408-11. [PMID: 23089369 DOI: 10.1016/j.atherosclerosis.2012.09.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]